Cargando…
Design and engineering of a transmissible antiviral defense
BACKGROUND: We propose, model, and implement a novel system of population-level intervention against a virus. One context is a treatment against a chronic infection such as HIV. The underlying principle is a form of virus ‘wars’ in which a benign, transmissible agent is engineered to protect against...
Autores principales: | Paff, Matthew L., Nuismer, Scott L., Ellington, Andrew D., Molineux, Ian J., May, Ryan H., Bull, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062863/ https://www.ncbi.nlm.nih.gov/pubmed/27752283 http://dx.doi.org/10.1186/s13036-016-0033-4 |
Ejemplares similares
-
Virus wars: using one virus to block the spread of another
por: Paff, Matthew L., et al.
Publicado: (2016) -
Viral attenuation by engineered protein fragmentation
por: Garry, Daniel J, et al.
Publicado: (2018) -
Therapeutic Application of Phage Capsule Depolymerases against K1, K5, and K30 Capsulated E. coli in Mice
por: Lin, Han, et al.
Publicado: (2017) -
Antibiotic Therapy Using Phage Depolymerases: Robustness Across a Range of Conditions
por: Lin, Han, et al.
Publicado: (2018) -
Experimental evolution of UV resistance in a phage
por: Tom, Eric F., et al.
Publicado: (2018)